DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Salloway S, Sperling R, Keren R. , et al; ELND005-AD201 Investigators.
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.
Neurology 2011;
77 (13) 1253-1262
We do not assume any responsibility for the contents of the web pages of other providers.